---
title: "RBC Capital maintains NNN REIT at Sector Perform, raises price target to $43 from $42"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304517485.md"
description: "RBC Capital maintained NNN REIT at Sector Perform and raised its price target to $43 from $42, a 2.4% increase.The price target implies an upside of 3.3% from the Nov 4 close of $41.63.Explore more price target data and ratings for NNN REIT on the , and track all previous and future analyst recommendations in the dedicated News Flow.DisclaimerSelect reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice."
datetime: "2026-11-05T19:40:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304517485.md)
  - [en](https://longbridge.com/en/news/304517485.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304517485.md)
generator: "portal-rs"
---

# RBC Capital maintains NNN REIT at Sector Perform, raises price target to $43 from $42

RBC Capital maintained NNN REIT at Sector Perform and raised its price target to $43 from $42, a 2.4% increase.

The price target implies an upside of 3.3% from the Nov 4 close of $41.63.

Explore more price target data and ratings for NNN REIT on the , and track all previous and future analyst recommendations in the dedicated News Flow.

**Disclaimer**

Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [NNN.US](https://longbridge.com/en/quote/NNN.US.md)

## Related News & Research

- [Truist Securities maintains NNN REIT at Hold, raises price target to $46 from $45](https://longbridge.com/en/news/305040077.md)
- [NNN REIT (NYSE:NNN) Announces Earnings Results](https://longbridge.com/en/news/304381650.md)
- [NNN: Occupancy rose to 99.2%, per-share Core FFO grew 5.9%, and disposition guidance increased](https://longbridge.com/en/news/304285634.md)
- [NNN REIT Q3 revenue beats estimates, raises 2026 disposition guidance](https://longbridge.com/en/news/304286434.md)
- [Cantor Fitzgerald maintains Zevra Therapeutics at Overweight, lowers price target to $19 from $25](https://longbridge.com/en/news/305495771.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**